{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:11Z","timestamp":1791925691742,"version":"4.3.4"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11030-024-10869-x","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T14:02:32Z","timestamp":1722434552000},"page":"783-816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Scaffolds imparting anthelmintic activity: recent advancements and SAR studies"],"prefix":"10.1007","volume":"29","author":[{"given":"Pawan","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh Kumar","family":"Rangra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"issue":"1","key":"10869_CR1","doi-asserted-by":"crossref","first-page":"e41568","DOI":"10.2196\/41568","volume":"9","author":"E Candela","year":"2023","unstructured":"Candela E et al (2023) The relationship between soil-transmitted helminth infections and environmental factors in Puerto Iguaz\u00fa, Argentina: cross-sectional study. JMIR Public Health Surveill 9(1):e41568","journal-title":"JMIR Public Health Surveill"},{"issue":"12","key":"10869_CR2","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1017\/S0031182019001021","volume":"146","author":"ML Ledger","year":"2019","unstructured":"Ledger ML et al (2019) Intestinal parasites at the Late Bronze Age settlement of Must Farm, in the fens of East Anglia, UK (9th century BCE). Parasitology 146(12):1583\u20131594","journal-title":"Parasitology"},{"issue":"4","key":"10869_CR3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI34261","volume":"118","author":"PJ Hotez","year":"2008","unstructured":"Hotez PJ et al (2008) Helminth infections: the great neglected tropical diseases. J Clin Investig 118(4):1311\u20131321","journal-title":"J Clin Investig"},{"key":"10869_CR4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-0348-7090-0_19","volume-title":"Progress in drug research\/Fortschritte der Arzneimittelforschung\/Progr\u00e8s des recherches pharmaceutiques: tropical diseases II\/Tropische Krankheiten II\/Maladies tropicales II","author":"U Sheth","year":"1975","unstructured":"Sheth U (1975) Mechanisms of anthelmintic action. Progress in drug research\/Fortschritte der Arzneimittelforschung\/Progr\u00e8s des recherches pharmaceutiques: tropical diseases II\/Tropische Krankheiten II\/Maladies tropicales II. Springer, pp 147\u2013157"},{"issue":"7","key":"10869_CR5","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/agriculture13071359","volume":"13","author":"L Hamid","year":"2023","unstructured":"Hamid L et al (2023) An insight into the global problem of gastrointestinal helminth infections amongst livestock: does nanotechnology provide an alternative? Agriculture 13(7):1359","journal-title":"Agriculture"},{"key":"10869_CR6","first-page":"51","volume":"123","author":"I de Tours","year":"2024","unstructured":"de Tours I (2024) Getting around the roundworms: identifying knowledge gaps and research priorities for the ascarids. Adv Parasitol 123:51\u2013123","journal-title":"Adv Parasitol"},{"issue":"8","key":"10869_CR7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijpara.2022.11.012","volume":"53","author":"C Britton","year":"2023","unstructured":"Britton C et al (2023) New technologies to study helminth development and host-parasite interactions. Int J Parasitol 53(8):393\u2013403","journal-title":"Int J Parasitol"},{"key":"10869_CR8","unstructured":"Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/search?cond=anthelmintic%20agent&start=2018-03-14_2024-03-14&aggFilters=results:with"},{"key":"10869_CR9","first-page":"1","volume-title":"WormBook: the online review of C. elegans biology","author":"L Holden-Dye","year":"2014","unstructured":"Holden-Dye L, Walker R (2014) Anthelmintic drugs and nematocides: studies in Caenorhabditis elegans. WormBook: the online review of C. elegans biology. pp 1\u201329"},{"issue":"7","key":"10869_CR10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/00397911.2019.1695276","volume":"50","author":"ZA Bhavsar","year":"2020","unstructured":"Bhavsar ZA et al (2020) Recent advances in development of anthelmintic agents: synthesis and biological screening. Synth Commun 50(7):917\u2013946","journal-title":"Synth Commun"},{"key":"10869_CR11","unstructured":"Rehan A (2020) Design, synthesis and biological evaluation of novel targeted anthelmintic agents. Thesis"},{"key":"10869_CR12","doi-asserted-by":"crossref","first-page":"136716","DOI":"10.1016\/j.molstruc.2023.136716","volume":"1295","author":"P Pattanayak","year":"2023","unstructured":"Pattanayak P et al (2023) Benzimidazoles in helminthiasis chemotherapy: developments and challenges. J Mol Struct 1295:136716","journal-title":"J Mol Struct"},{"issue":"2","key":"10869_CR13","first-page":"88","volume":"94","author":"K Hajnal","year":"2021","unstructured":"Hajnal K et al (2021) Chemical and pharmacological characterization of anthelmintic benzimidazoles. Bull Med Sci 94(2):88\u201396","journal-title":"Bull Med Sci"},{"issue":"7","key":"10869_CR14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/ciab730","volume":"74","author":"J Jacob","year":"2022","unstructured":"Jacob J et al (2022) Clinical efficacy and safety of albendazole and other benzimidazole anthelmintics for rat lungworm disease (neuroangiostrongyliasis): a systematic analysis of clinical reports and animal studies. Clin Infect Dis 74(7):1293\u20131302","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10869_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/41.2.145","volume":"41","author":"P Venkatesan","year":"1998","unstructured":"Venkatesan P (1998) Albendazole. J Antimicrob Chemother 41(2):145\u2013147","journal-title":"J Antimicrob Chemother"},{"issue":"1\u20132","key":"10869_CR16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0001-706X(96)00640-7","volume":"64","author":"R Horton","year":"1997","unstructured":"Horton R (1997) Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop 64(1\u20132):79\u201393","journal-title":"Acta Trop"},{"issue":"8","key":"10869_CR17","first-page":"15","volume":"3","author":"WR Ali","year":"2015","unstructured":"Ali WR, Ibrahim ZI, Ibrahim AAJ (2015) Study the histopathology of Immuno-therapy trail in mice infected with hydatid cysts. Int J Res 3(8):15\u201322","journal-title":"Int J Res"},{"issue":"Suppl1","key":"10869_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1179\/000349809X12502035776595","volume":"103","author":"J Horton","year":"2009","unstructured":"Horton J (2009) The development of albendazole for lymphatic filariasis. Ann Trop Med Parasitol 103(Suppl1):33\u201340","journal-title":"Ann Trop Med Parasitol"},{"issue":"9","key":"10869_CR19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-3156.2005.01458.x","volume":"10","author":"J Critchley","year":"2005","unstructured":"Critchley J et al (2005) Albendazole for the control and elimination of lymphatic filariasis: systematic review. Trop Med Int Health 10(9):818\u2013825","journal-title":"Trop Med Int Health"},{"key":"10869_CR20","first-page":"CD003753","volume":"4","author":"D Addiss","year":"2005","unstructured":"Addiss D et al (2005) Albendazole for lymphatic filariasis. Cochrane Database Syst Rev 4:CD003753","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10869_CR21","doi-asserted-by":"crossref","first-page":"e0272821","DOI":"10.1371\/journal.pone.0272821","volume":"17","author":"MZ Tee","year":"2022","unstructured":"Tee MZ et al (2022) Efficacy of triple dose albendazole treatment for soil-transmitted helminth infections. PLoS ONE 17(8):e0272821","journal-title":"PLoS ONE"},{"issue":"2","key":"10869_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12639-019-01091-w","volume":"43","author":"M Bushra","year":"2019","unstructured":"Bushra M et al (2019) Efficacy of closantel, fenbendazole and ivermectin against GI helminths of cattle in central Kashmir. J Parasit Dis 43(2):289\u2013293","journal-title":"J Parasit Dis"},{"key":"10869_CR23","doi-asserted-by":"crossref","first-page":"120957","DOI":"10.1016\/j.ijpharm.2021.120957","volume":"607","author":"AI Varlamova","year":"2021","unstructured":"Varlamova AI et al (2021) Pharmacokinetic profile, tissue residue depletion and anthelmintic efficacy of supramolecular fenbendazole. Int J Pharm 607:120957","journal-title":"Int J Pharm"},{"issue":"8","key":"10869_CR24","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3889\/oamjms.2019.299","volume":"7","author":"EJ Anto","year":"2019","unstructured":"Anto EJ, Nugraha SE (2019) Efficacy of albendazole and mebendazole with or without levamisole for ascariasis and trichuriasis. Open Access Macedonian J Med Sci 7(8):1299","journal-title":"Open Access Macedonian J Med Sci"},{"issue":"5","key":"10869_CR25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0035-9203(83)90199-2","volume":"77","author":"S Kan","year":"1983","unstructured":"Kan S (1983) The anthelmintic effects of flubendazole on Trichuris trichiura and Ascaris iumbricoides. Trans R Soc Trop Med Hyg 77(5):668\u2013670","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10869_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0022149X09321173","volume":"83","author":"I Fairweather","year":"2009","unstructured":"Fairweather I (2009) Triclabendazole progress report, 2005\u20132009: an advancement of learning? J Helminthol 83(2):139\u2013150","journal-title":"J Helminthol"},{"issue":"12","key":"10869_CR27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1517\/13543784.14.12.1513","volume":"14","author":"J Keiser","year":"2005","unstructured":"Keiser J et al (2005) Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs 14(12):1513\u20131526","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10869_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2885.1990.tb00773.x","volume":"13","author":"Q McKellar","year":"1990","unstructured":"McKellar Q, Scott E (1990) The benzimidazole anthelmintic agents\u2014a review. J Vet Pharmacol Ther 13(3):223\u2013247","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"10869_CR29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1476-5381.1970.tb10601.x","volume":"38","author":"J Aceves","year":"1970","unstructured":"Aceves J, Erlij D, Martinez-Maranon R (1970) The mechanism of the paralysing action of tetramisole on Ascaris somatic muscle. Br J Pharmacol 38(3):602","journal-title":"Br J Pharmacol"},{"key":"10869_CR30","volume-title":"Pharmacokinetics and pharmacodynamics of anti-infective and anti-inflammatory drugs in animals","author":"QA McKellar","year":"2001","unstructured":"McKellar QA (2001) Pharmacokinetics and pharmacodynamics of anti-infective and anti-inflammatory drugs in animals. University of Glasgow"},{"issue":"5","key":"10869_CR31","first-page":"102","volume":"19","author":"W Hatchuel","year":"1973","unstructured":"Hatchuel W (1973) A new anthelminthic-comhantrin (Pyrantel Pamoate). Cent Afr J Med 19(5):102\u2013104","journal-title":"Cent Afr J Med"},{"issue":"2","key":"10869_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tvjl.2007.06.021","volume":"178","author":"SR Kopp","year":"2008","unstructured":"Kopp SR et al (2008) Pyrantel in small animal medicine: 30 years on. Vet J 178(2):177\u2013184","journal-title":"Vet J"},{"issue":"7","key":"10869_CR33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1301956","volume":"370","author":"B Speich","year":"2014","unstructured":"Speich B et al (2014) Oxantel pamoate\u2013albendazole for Trichuris trichiura infection. N Engl J Med 370(7):610\u2013620","journal-title":"N Engl J Med"},{"issue":"1","key":"10869_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/med.2610130103","volume":"13","author":"WC Campbell","year":"1993","unstructured":"Campbell WC (1993) Ivermectin, an antiparasitic agent. Med Res Rev 13(1):61\u201379","journal-title":"Med Res Rev"},{"issue":"2","key":"10869_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1472-8206.2003.00170.x","volume":"17","author":"D Richard-Lenoble","year":"2003","unstructured":"Richard-Lenoble D, Chandenier J, Gaxotte P (2003) Ivermectin and filariasis. Fundam Clin Pharmacol 17(2):199\u2013203","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"10869_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","volume":"87","author":"A Crump","year":"2011","unstructured":"Crump A, Omura S (2011) Ivermectin, \u2018wonder drug\u2019 from Japan: the human use perspective. Proc Jpn Acad B 87(2):13\u201328","journal-title":"Proc Jpn Acad B"},{"issue":"6","key":"10869_CR37","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2174\/138920112800399248","volume":"13","author":"P Gonzalez","year":"2012","unstructured":"Gonzalez P, Gonz\u00e1lez FA, Ueno K (2012) Ivermectin in human medicine, an overview of the current status of its clinical applications. Curr Pharm Biotechnol 13(6):1103\u20131109","journal-title":"Curr Pharm Biotechnol"},{"issue":"13","key":"10869_CR38","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1017\/S0031182014001401","volume":"141","author":"L Lecova","year":"2014","unstructured":"Lecova L et al (2014) Monepantel: the most studied new anthelmintic drug of recent years. Parasitology 141(13):1686\u20131698","journal-title":"Parasitology"},{"issue":"7184","key":"10869_CR39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nature06722","volume":"452","author":"R Kaminsky","year":"2008","unstructured":"Kaminsky R et al (2008) A new class of anthelmintics effective against drug-resistant nematodes. Nature 452(7184):176\u2013180","journal-title":"Nature"},{"key":"10869_CR40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/9783527652969.ch18","volume-title":"Parasitic helminths: targets, screens, drugs and vaccines","author":"DJ Woods","year":"2012","unstructured":"Woods DJ et al (2012) Discovery, mode of action, and commercialization of derquantel. Parasitic helminths: targets, screens, drugs and vaccines. Wiley, pp 297\u2013307"},{"issue":"1","key":"10869_CR41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.exppara.2011.08.012","volume":"132","author":"R Martin","year":"2012","unstructured":"Martin R et al (2012) Emodepside and SL0-1 potassium channels: a review. Exp Parasitol 132(1):40\u201346","journal-title":"Exp Parasitol"},{"issue":"10","key":"10869_CR42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1358\/dof.2004.029.10.863392","volume":"29","author":"K Amliwala","year":"2004","unstructured":"Amliwala K et al (2004) Emodepside, a cyclo-octadepsipeptide anthelmintic with a novel mode of action. Drugs Future 29(10):1015\u20131024","journal-title":"Drugs Future"},{"issue":"9","key":"10869_CR43","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2174\/138945006778226552","volume":"7","author":"S Mitchell","year":"2006","unstructured":"Mitchell S (2006) Phenothiazine: the parent molecule. Curr Drug Targets 7(9):1181\u20131189","journal-title":"Curr Drug Targets"},{"issue":"3\u20134","key":"10869_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drudis.2011.01.001","volume":"16","author":"MJ Ohlow","year":"2011","unstructured":"Ohlow MJ, Moosmann B (2011) Phenothiazine: the seven lives of pharmacology\u2019s first lead structure. Drug Discov Today 16(3\u20134):119\u2013131","journal-title":"Drug Discov Today"},{"issue":"2","key":"10869_CR45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0021-9258(18)69550-X","volume":"235","author":"H Barker","year":"1960","unstructured":"Barker H et al (1960) Isolation and properties of crystalline cobamide coenzymes containing benzimidazole or 5,6-dimethylbenzimidazole. J Biol Chem 235(2):480\u2013488","journal-title":"J Biol Chem"},{"key":"10869_CR46","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/2091084a0","volume":"209","author":"D Thienpont","year":"1966","unstructured":"Thienpont D (1966) Tetramisole (R 8299), a new, potent broad spectrum anthelmintic. Nature 209:1084\u20131086","journal-title":"Nature"},{"issue":"108","key":"10869_CR47","first-page":"1512","volume":"25","author":"J Drudge","year":"1964","unstructured":"Drudge J et al (1964) Field studies on parasite control in sheep: comparison of thia-bendazole, ruelene, and phenothiazine. Am J Vet Res 25(108):1512\u20131518","journal-title":"Am J Vet Res"},{"key":"10869_CR48","volume-title":"Microtubules","author":"P Dustin","year":"2012","unstructured":"Dustin P (2012) Microtubules. Springer Science & Business Media"},{"issue":"12","key":"10869_CR49","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ejmech.2006.07.005","volume":"41","author":"AT Mavrova","year":"2006","unstructured":"Mavrova AT et al (2006) Antihelminthic activity of some newly synthesized 5(6)-(un)substituted-1H-benzimidazol-2-ylthioacetylpiperazine derivatives. Eur J Med Chem 41(12):1412\u20131420","journal-title":"Eur J Med Chem"},{"key":"10869_CR50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00044-010-9344-z","volume":"20","author":"H Aryapour","year":"2011","unstructured":"Aryapour H et al (2011) Biological evaluation of synthetic analogues of curcumin: chloro-substituted-2\u2032-hydroxychalcones as potential inhibitors of tubulin polymerization and cell proliferation. Med Chem Res 20:503\u2013510","journal-title":"Med Chem Res"},{"issue":"7","key":"10869_CR51","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1016\/j.ejmech.2011.03.017","volume":"46","author":"R Satyendra","year":"2011","unstructured":"Satyendra R et al (2011) Synthesis, in vitro antioxidant, anthelmintic and molecular docking studies of novel dichloro substituted benzoxazole-triazolo-thione derivatives. Eur J Med Chem 46(7):3078\u20133084","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10869_CR52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/acve-2017-0013","volume":"67","author":"M Abongwa","year":"2017","unstructured":"Abongwa M, Martin RJ, Robertson AP (2017) A brief review on the mode of action of antinematodal drugs. Acta Vet 67(2):137\u2013152","journal-title":"Acta Vet"},{"issue":"23","key":"10869_CR53","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1021\/ol302856w","volume":"14","author":"TB Nguyen","year":"2012","unstructured":"Nguyen TB et al (2012) Benzazoles from aliphatic amines and o-amino\/mercaptan\/hydroxyanilines: elemental sulfur as a highly efficient and traceless oxidizing agent. Org Lett 14(23):5948\u20135951","journal-title":"Org Lett"},{"issue":"3","key":"10869_CR54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/cr60151a002","volume":"48","author":"JB Wright","year":"1951","unstructured":"Wright JB (1951) The chemistry of the benzimidazoles. Chem Rev 48(3):397\u2013541","journal-title":"Chem Rev"},{"issue":"7","key":"10869_CR55","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0020-7519(88)90175-0","volume":"18","author":"E Lacey","year":"1988","unstructured":"Lacey E (1988) The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int J Parasitol 18(7):885\u2013936","journal-title":"Int J Parasitol"},{"key":"10869_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12039-020-01881-3","volume":"133","author":"B Kharrngi","year":"2021","unstructured":"Kharrngi B et al (2021) Developing a highly potent anthelmintic: study of catalytic application of L-proline derived aminothiourea in rapid synthesis of biscoumarins and their in vitro anthelmintic essay. J Chem Sci 133:1\u201315","journal-title":"J Chem Sci"},{"key":"10869_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12039-019-1689-3","volume":"132","author":"G Basumatary","year":"2020","unstructured":"Basumatary G et al (2020) Coumarin-based trisubstituted methanes as potent anthelmintic: synthesis, molecular docking and in vitro efficacy. J Chem Sci 132:1\u201312","journal-title":"J Chem Sci"},{"key":"10869_CR58","doi-asserted-by":"crossref","first-page":"106287","DOI":"10.1016\/j.bioorg.2022.106287","volume":"131","author":"P Laohapaisan","year":"2023","unstructured":"Laohapaisan P et al (2023) Discovery of N-methylbenzo[d]oxazol-2-amine as new anthelmintic agent through scalable protocol for the synthesis of N-alkylbenzo[d]oxazol-2-amine and N-alkylbenzo[d]thiazol-2-amine derivatives. Bioorg Chem 131:106287","journal-title":"Bioorg Chem"},{"issue":"1","key":"10869_CR59","doi-asserted-by":"crossref","first-page":"23437","DOI":"10.1038\/s41598-021-02792-0","volume":"11","author":"CS Morais","year":"2021","unstructured":"Morais CS et al (2021) Pyrazoline derivatives as promising novel antischistosomal agents. Sci Rep 11(1):23437","journal-title":"Sci Rep"},{"issue":"14","key":"10869_CR60","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.3390\/molecules27144488","volume":"27","author":"R Paprocka","year":"2022","unstructured":"Paprocka R et al (2022) Evaluation of anthelmintic and anti-inflammatory activity of 1,2,4-triazole derivatives. Molecules 27(14):4488","journal-title":"Molecules"},{"key":"10869_CR61","doi-asserted-by":"crossref","first-page":"112554","DOI":"10.1016\/j.ejmech.2020.112554","volume":"208","author":"N Escala","year":"2020","unstructured":"Escala N et al (2020) Synthesis, bioevaluation and docking studies of some 2-phenyl-1H-benzimidazole derivatives as anthelminthic agents against the nematode Teladorsagia circumcincta. Eur J Med Chem 208:112554","journal-title":"Eur J Med Chem"},{"key":"10869_CR62","doi-asserted-by":"crossref","first-page":"133735","DOI":"10.1016\/j.molstruc.2022.133735","volume":"1269","author":"N Escala","year":"2022","unstructured":"Escala N et al (2022) Further and new target-based benzimidazole anthelmintics active against Teladorsagia circumcincta. J Mol Struct 1269:133735","journal-title":"J Mol Struct"},{"issue":"12","key":"10869_CR63","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.52711\/0974-360X.2021.01101","volume":"14","author":"PS Tajane","year":"2021","unstructured":"Tajane PS et al (2021) Synthesis and molecular modeling studies of 2-[2-(3-nitrophenyl)-1H-benzimidazol-1-yl]-acetamide derivatives as anthelmintic. Res J Pharm Technol 14(12):6369\u20136373","journal-title":"Res J Pharm Technol"},{"issue":"3","key":"10869_CR64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5958\/2231-5691.2019.00035.2","volume":"9","author":"S Mahaparale","year":"2019","unstructured":"Mahaparale S, Banju D (2019) Recent analytical methods of anti-helmintic agents. Asian J Pharm Res 9(3):209\u2013218","journal-title":"Asian J Pharm Res"},{"issue":"1","key":"10869_CR65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1134\/S1070428022010146","volume":"58","author":"P Pattanayak","year":"2022","unstructured":"Pattanayak P, Saravanan K (2022) Synthesis and biological activity of some novel metronidazole derivatives containing a 1,3,4-thiadiazole Schiff base moiety. Russ J Org Chem 58(1):99\u2013105","journal-title":"Russ J Org Chem"},{"issue":"8","key":"10869_CR66","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","volume":"16","author":"A Lagunin","year":"2000","unstructured":"Lagunin A et al (2000) PASS: prediction of activity spectra for biologically active substances. Bioinformatics 16(8):747\u2013748","journal-title":"Bioinformatics"},{"key":"10869_CR67","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1134\/S106816202302019X","volume":"49","author":"P Pattanayak","year":"2023","unstructured":"Pattanayak P, Mishra G (2023) Docking and PASS-assisted evaluation of furaldehyde substituted benzimidazoles as anthelmintic agents. Russ J Bioorg Chem 49:403\u2013411","journal-title":"Russ J Bioorg Chem"},{"key":"10869_CR68","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acsinfecdis.5b00097","volume":"1","author":"H Zgurskaya","year":"2015","unstructured":"Zgurskaya H, Lopez C, Gnanakaran S (2015) Permeability barrier of Gram-negative cell envelopes and approaches to bypass it. ACS Infect Dis 1:512\u2013522","journal-title":"ACS Infect Dis"},{"issue":"1\u20133","key":"10869_CR69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA et al (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23(1\u20133):3\u201325","journal-title":"Adv Drug Deliv Rev"},{"key":"10869_CR70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11094-023-02872-7","volume":"57","author":"P Pattanayak","year":"2023","unstructured":"Pattanayak P, Behera K, Behera PR (2023) Synthetic clubbing of 2-methyl-5-nitroimidazole with 5(6)-substituted-1H-benzimidazole as potential antimicrobial and anthelmintic agents. Pharm Chem J 57:227\u2013233","journal-title":"Pharm Chem J"},{"issue":"11","key":"10869_CR71","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","volume":"49","author":"R Thomsen","year":"2006","unstructured":"Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49(11):3315\u20133321","journal-title":"J Med Chem"},{"key":"10869_CR72","unstructured":"Soni N, Gangwar A, Soni N (2019) Synthesis, molecular docking studies and in vitro anthelmintic activities of novel substituted pyrazole bearing benzimidazole derivatives. Pharma Innovation 8(5):327\u2013332"},{"issue":"3","key":"10869_CR73","first-page":"258","volume":"5","author":"T Sravani","year":"2015","unstructured":"Sravani T, Paarakh PM, Shruthi S (2015) In silico and in vitro anthelmintic activity of \u03b2-sitosterol isolated from rhizomes of Hedychium spicatum Buch.-Ham. Indian J Nat Prod Resour 5(3):258\u2013261","journal-title":"Indian J Nat Prod Resour"},{"issue":"11","key":"10869_CR74","first-page":"1152","volume":"8","author":"SA Katti","year":"2019","unstructured":"Katti SA et al (2019) Synthesis, molecular docking & evaluation of anthelmintic activity of 2-(2-amino phenyl)-1H-benzimidazole derivatives. World J Pharm Res 8(11):1152\u20131163","journal-title":"World J Pharm Res"},{"key":"10869_CR75","doi-asserted-by":"crossref","first-page":"109540","DOI":"10.1016\/j.cbi.2021.109540","volume":"345","author":"K Anichina","year":"2021","unstructured":"Anichina K et al (2021) 1H-Benzimidazole-2-yl hydrazones as tubulin-targeting agents: synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studies. Chem Biol Interact 345:109540","journal-title":"Chem Biol Interact"},{"issue":"63","key":"10869_CR76","doi-asserted-by":"crossref","first-page":"39848","DOI":"10.1039\/D1RA07419A","volume":"11","author":"MA Argirova","year":"2021","unstructured":"Argirova MA et al (2021) New 1H-benzimidazole-2-yl hydrazones with combined antiparasitic and antioxidant activity. RSC Adv 11(63):39848\u201339868","journal-title":"RSC Adv"},{"key":"10869_CR77","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1007\/s00044-014-1015-z","volume":"23","author":"ZS Saify","year":"2014","unstructured":"Saify ZS et al (2014) 2-(2\u2032-Pyridyl) benzimidazole derivatives and their urease inhibitory activity. Med Chem Res 23:4447\u20134454","journal-title":"Med Chem Res"},{"issue":"3","key":"10869_CR78","first-page":"827","volume":"31","author":"N Asghar","year":"2018","unstructured":"Asghar N et al (2018) Synthesis, characterization and SAR of novel bezimidazole derivatives as nematicidal agents. Pak J Pharm Sci 31(3):827\u2013833","journal-title":"Pak J Pharm Sci"},{"issue":"2","key":"10869_CR79","first-page":"300","volume":"3","author":"L Keshwani","year":"2023","unstructured":"Keshwani L et al (2023) Synthesis and characterization of novel benzimidazole derivative as potent anthelmintic agent. Curr Sci 3(2):300\u2013307","journal-title":"Curr Sci"},{"issue":"11","key":"10869_CR80","first-page":"76","volume":"10","author":"B Shivakumar","year":"2018","unstructured":"Shivakumar B et al (2018) Synthesis and evaluation of 4-(2-Chloroquinolin-3-yl)-6-(6-Methyl-1H-benzimidazol-2-yl) pyrimidin-2-amines as potent anthelmintic agents. J Chem Pharm Res 10(11):76\u201383","journal-title":"J Chem Pharm Res"},{"key":"10869_CR81","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s12639-014-0560-1","volume":"40","author":"Vijaya","year":"2016","unstructured":"Vijaya, Yadav AK (2016) In vitro anthelmintic assessment of selected phytochemicals against Hymenolepis diminuta, a zoonotic tapeworm. J Parasitic Dis 40:1082\u20131086","journal-title":"J Parasitic Dis"},{"issue":"3","key":"10869_CR82","doi-asserted-by":"crossref","first-page":"e0003604","DOI":"10.1371\/journal.pntd.0003604","volume":"9","author":"J Edwards","year":"2015","unstructured":"Edwards J et al (2015) The diterpenoid 7-keto-sempervirol, derived from Lycium chinense, displays anthelmintic activity against both Schistosoma mansoni and Fasciola hepatica. PLoS Negl Trop Dis 9(3):e0003604","journal-title":"PLoS Negl Trop Dis"},{"key":"10869_CR83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2018.04.032","volume":"152","author":"A Crusco","year":"2018","unstructured":"Crusco A et al (2018) Design, synthesis and anthelmintic activity of 7-keto-sempervirol analogues. Eur J Med Chem 152:87\u2013100","journal-title":"Eur J Med Chem"},{"issue":"08","key":"10869_CR84","first-page":"1","volume":"1","author":"SS Chaudhari","year":"2023","unstructured":"Chaudhari SS et al (2023) Synthesis and evaluation of novel N-(6-nitrobenzo[d]thiazol-2-yl)-2-acetamide as anthelmintic activity. Int J Pharm Sci 1(08):1\u20131","journal-title":"Int J Pharm Sci"},{"issue":"7","key":"10869_CR85","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/00397911.2018.1426101","volume":"48","author":"AN Nadaf","year":"2018","unstructured":"Nadaf AN, Shivashankar K (2018) CFL light promoted one-pot synthesis of pyrano[3, 2-c]chromen-5 (4H)-ones. Synth Commun 48(7):809\u2013815","journal-title":"Synth Commun"},{"issue":"2","key":"10869_CR86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/00397911.2021.2016836","volume":"52","author":"GK Kharmawlong","year":"2022","unstructured":"Kharmawlong GK et al (2022) A new approach for the synthesis of biologically active chromene compounds using a photo catalyst TiO2-Ag. Synth Commun 52(2):229\u2013249","journal-title":"Synth Commun"},{"issue":"4","key":"10869_CR87","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jsps.2020.02.002","volume":"28","author":"W Tejchman","year":"2020","unstructured":"Tejchman W et al (2020) Antibacterial properties of 5-substituted derivatives of rhodanine-3-carboxyalkyl acids. Part II. Saudi Pharm J 28(4):414\u2013426","journal-title":"Saudi Pharm J"},{"issue":"7","key":"10869_CR88","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/molecules27072155","volume":"27","author":"W Tejchman","year":"2022","unstructured":"Tejchman W et al (2022) Discovery of cinnamylidene derivative of rhodanine with high anthelmintic activity against Rhabditis sp. Molecules 27(7):2155","journal-title":"Molecules"},{"issue":"20","key":"10869_CR89","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1016\/j.bmc.2017.07.057","volume":"25","author":"SS Thakkar","year":"2017","unstructured":"Thakkar SS et al (2017) Benzothiazole analogues: synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities. Bioorg Med Chem 25(20):5396\u20135406","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"10869_CR90","first-page":"81","volume":"19","author":"U Agarwal","year":"2023","unstructured":"Agarwal U et al (2023) Synthesis, ADME, molecular docking and biological evaluation of new 2-aminobenzothiazloes. Curr Bioact Compd 19(9):81\u201394","journal-title":"Curr Bioact Compd"},{"issue":"12","key":"10869_CR91","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2174\/1570178620666230703111452","volume":"20","author":"R Das","year":"2023","unstructured":"Das R et al (2023) Microwave-assisted synthesis, molecular docking study of spirofused heterocycles as anti-microbial and anthelmintic potential. Lett Org Chem 20(12):1182\u20131191","journal-title":"Lett Org Chem"},{"issue":"5","key":"10869_CR92","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1021\/acsinfecdis.1c00025","volume":"7","author":"FA Partridge","year":"2021","unstructured":"Partridge FA et al (2021) Structural requirements for dihydrobenzoxazepinone anthelmintics: actions against medically important and model parasites: Trichuris muris, Brugia malayi, Heligmosomoides polygyrus, and Schistosoma mansoni. ACS Infect Dis 7(5):1260\u20131274","journal-title":"ACS Infect Dis"},{"issue":"2","key":"10869_CR93","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/jo00176a013","volume":"49","author":"A Padwa","year":"1984","unstructured":"Padwa A, Koehler KF, Rodriguez A (1984) New synthesis of beta-lactams based on nitrone cycloaddition to nitroalkenes. J Org Chem 49(2):282\u2013288","journal-title":"J Org Chem"},{"issue":"10","key":"10869_CR94","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/adsc.202100013","volume":"363","author":"NG Alves","year":"2021","unstructured":"Alves NG et al (2021) Recent advances in the synthesis of spiro-\u03b2-lactams and spiro-\u03b4-lactams. Adv Synth Catal 363(10):2464\u20132501","journal-title":"Adv Synth Catal"},{"issue":"4","key":"10869_CR95","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5267\/j.ccl.2022.5.001","volume":"11","author":"P Mondal","year":"2022","unstructured":"Mondal P, Mondal S (2022) Synthesis, characterization and SAR studies of novel series of spiro \u03b2-lactam of 5-methyl-indole-2, 3-dione derivatives as a potential antibacterial and anthelmintic agent. Curr Chem Lett 11(4):403\u2013414","journal-title":"Curr Chem Lett"},{"issue":"2","key":"10869_CR96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11094-022-02620-3","volume":"56","author":"P Pattanayak","year":"2022","unstructured":"Pattanayak P, Kaliyaperumal S (2022) Design, synthesis, characterization and in vitro antimicrobial and anthelmintic evaluation of metronidazole derivatives modified at position 1. Pharm Chem J 56(2):191\u2013196","journal-title":"Pharm Chem J"},{"issue":"1","key":"10869_CR97","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1570180814666170710160751","volume":"15","author":"A Husain","year":"2018","unstructured":"Husain A et al (2018) Nalidixic acid Schiff bases: synthesis and biological evaluation. Lett Drug Des Discov 15(1):103\u2013111","journal-title":"Lett Drug Des Discov"},{"issue":"6","key":"10869_CR98","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1747-0285.2012.01354.x","volume":"79","author":"CM Menezes","year":"2012","unstructured":"Menezes CM et al (2012) Synthesis, biological evaluation, and structure\u2013activity relationship of clonazepam, meclonazepam, and 1,4-benzodiazepine compounds with schistosomicidal activity. Chem Biol Drug Des 79(6):943\u2013949","journal-title":"Chem Biol Drug Des"},{"issue":"13","key":"10869_CR99","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.3390\/molecules28135034","volume":"28","author":"K Anichina","year":"2023","unstructured":"Anichina K et al (2023) Fused triazinobenzimidazoles bearing heterocyclic moiety: synthesis, structure investigations, and in silico and in vitro biological activity. Molecules 28(13):5034","journal-title":"Molecules"},{"issue":"1\u20132","key":"10869_CR100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1\u20132):55\u201363","journal-title":"J Immunol Methods"},{"key":"10869_CR101","unstructured":"Long A, Wilkinson DE (2020) Anthelmintic compounds, compositions and method of using thereof. Patent No. AU2019202773B2, Australia, 02 Jul 2020"},{"key":"10869_CR102","unstructured":"Gribanyu N et al (2020) New anthelmintic compounds. Patent No. TW202030188A, Taiwan, 16 Aug 2020"},{"key":"10869_CR103","unstructured":"A Long, Gurrala SR (2020) Anthelmintic compounds. Patent No. EP3145925B1, European Patent Office, 04 Nov 2020"},{"key":"10869_CR104","unstructured":"Whipsch W et al (2021) Novel quinoline derivatives. Patent No. KR20210006401A, South Korea, 18 Jan 2021"},{"key":"10869_CR105","unstructured":"Alig B et al (2021) Isoquinoline derivatives and their use for the treatment of parasitic infections. Patent No. CA3147542A1, Canada, 04 Feb 2021"},{"key":"10869_CR106","unstructured":"Alig B et al (2021) New anthelmintic compounds. Patent application pending in Australia, AU2019368661A1, 29 Apr 2021"},{"key":"10869_CR107","unstructured":"Kuhlmann HF et al (2021) Anthelmintic heterocyclic compound. Patent application pending in Japan, JP2023528822A, 19 May 2021"},{"key":"10869_CR108","unstructured":"H\u00fcbsch W et al (2021) New anthelmintic quinoline-3-carboxamide derivative. Patent No. EP3538512B1, European Patent Office, 16 Jun 2021"},{"key":"10869_CR109","unstructured":"Bondsen B, Hammerland L (2021) Combination of anthelmintic and how to use it. Patent No. JP6899330B2, Japan, 07 Jul 2021"},{"key":"10869_CR110","unstructured":"Griebenow N et al (2021) New anthelmintic compounds. Patent No. EP3847168A2, European Patent Office, 14 Jul 2021"},{"key":"10869_CR111","unstructured":"Kohler A et al (2021) New pyrazolopyrimidine derivatives. Patent No. TWI742067B, Taiwan, 11 Oct 2021"},{"key":"10869_CR112","unstructured":"Griebenow N et al (2021) Substituted condensed azines as anthelmintic compounds. Patent No. CA3179528A1, Canada, 14 Oct 2021"},{"key":"10869_CR113","unstructured":"B\u00f6hm C et al (2022) Quinoline derivatives for treating infections with helminth. Patent No. AU2018311019B2, Australia, 26 May 2022"},{"key":"10869_CR114","unstructured":"De Fallois L et al (2022) Anthelmintic depsipeptide compounds. Patent No. ES2916216T3, Spain, 29 Jun 2022"},{"key":"10869_CR115","unstructured":"Castillo Bocanegra R et al (2022) Water-soluble compounds derived from benzimidazole, pharmaceutical composition and use of pharmaceutical composition. Patent No. BR112017010938B1, Brazil, 10 Aug 2022"},{"key":"10869_CR116","unstructured":"Griebenov N et al (2022) New bicyclic pyrazole derivatives. Patent No. RU2781426C2, Russia, 11 Oct 2022"},{"key":"10869_CR117","unstructured":"Griebenov N et al (2022) New bicyclic pyrazole derivatives. Patent No. RU2781426C9, Russia, 11 Oct 2022"},{"key":"10869_CR118","unstructured":"Gribanyu N et al (2022) New bicyclic pyrazole derivatives. Patent No. TWI780147B, Taiwan, 11 Oct 2022"},{"key":"10869_CR119","unstructured":"Griebenow N et al (2022) Substituted condensed azines as anthelmintic compounds. Patent No. AU2021253168A1, Australia, 03 Nov 2022"},{"key":"10869_CR120","unstructured":"Alig B et al (2022) New quinoline derivatives. Patent No. AU2019266511B2, Australia, 08 Dec 2022"},{"key":"10869_CR121","unstructured":"New quinoline derivatives. Patent application EP4148052A1, European Patent Office, 15 Mar 2023"},{"key":"10869_CR122","unstructured":"Bayer Animal Health Gmbh., New azaquinoline derivatives. Patent application filed in Israel, IL271607B2, 01 Jul 2023"},{"key":"10869_CR123","unstructured":"K\u00f6hler A et al (2023) Pyrazolopyrimidine derivatives. Patent No. EP3442974B1, European Patent Office, 12 Jul 2023"},{"key":"10869_CR124","unstructured":"Hubsey W et al (2023) New quinoline derivatives. Patent No. TWI813680B, Taiwan, 01 Sept 2023"},{"key":"10869_CR125","unstructured":"Griebenov N et al (2023) New bicyclic pyrazole derivatives. Patent No. KR102596307B1, South Korea, 30 Oct 2023"},{"issue":"9","key":"10869_CR126","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/cid\/ciad387","volume":"77","author":"A Sprecher","year":"2023","unstructured":"Sprecher A, Viviane P et al (2023) Efficacy and safety of moxidectin-albendazole and ivermectin-albendazole combination therapy compared to albendazole monotherapy in adolescents and adults infected with Trichuris trichiura: a randomized, controlled superiority trial. Clin Infect Dis 77(9):1294\u20131302","journal-title":"Clin Infect Dis"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10869-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10869-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10869-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T16:40:17Z","timestamp":1738341617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10869-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10869"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10869-x","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}